Autosomal dominant optic atrophy (ADOA), the most common genetic optic neuropathy, is an insidious disease. It often presents slowly during childhood by way of blurry vision, trouble reading or ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

Autosomal dominant optic atrophy (ADOA), the most common genetic optic neuropathy, is an insidious disease. It often presents slowly during childhood by way of blurry vision, trouble reading or ...

The newly published results of two small clinical trials suggest that two novel antibiotics could provide safer alternatives ...

Recent evidence has raised questions regarding the value of the traditional high-dose corticosteroids and optic nerve decompression approaches used for traumatic optic neuropathy.

Semaglutide use associated with increased risk for NAION at the 2-, 3-, and 4-year time point from the index date.

(HealthDay News) — For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION), according to ...

For individuals with type 2 diabetes, semaglutide is tied to a modestly increased risk for nonarteritic anterior ischemic optic neuropathy.

WEDNESDAY, Feb. 26, 2025 (HealthDay News) -- For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarteritic anterior ischemic optic ...

Human toxic peripheral neuropathies (TxPN) due to occupational chemical exposure are relatively rare compared with medically related peripheral neuropathies. They are however difficult to diagnose ...

Ultrasonographic evaluation of the optic nerve significantly can significantly aid the diagnosis of optic neuropathy in patients with SLE. NMUS should be regarded as an adjunct to conventional ...

TUESDAY, Jan. 14, 2025 (HealthDay News) -- Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy (NAION) in individuals with type 2 diabetes ...